NHS Framework - Blood Disorders including Haemophilia A and B - July 2024
Reference ocds-h6vhtk-043b0e · NHS England
Awarded to Takeda UK Ltd and 8 others.
Interested in tenders like this? Get the next tenders like this one published in the United Kingdom by email. Free, no card needed.
Amounts and figures
Description
Project Title: NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A and B - July 2024 Offer reference number: CM/PHS/22/5661 Period of framework: 1 July 2024 to 30 April 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 14 months. Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
Lots (23)
| Lot | Description | CPV code | Amount |
|---|---|---|---|
| 1 | CM/PHS/22/5661/01 Standard Half-life Recombinant Factor VIII | 33600000 Pharmaceutical products | — |
| 2 | CM/PHS/22/5661/02 Enhanced Half-life Recombinant Factor VIII | 33600000 Pharmaceutical products | — |
| 3 | CM/PHS/22/5661/03 Emicizumab | 33600000 Pharmaceutical products | — |
| 4 | CM/PHS/22/5661/04 eftrenonacog alfa (rFIX EHL) | 33600000 Pharmaceutical products | — |
| 5 | CM/PHS/22/5661/05 albutrepenonacog alfa (rFIX EHL) | 33600000 Pharmaceutical products | — |
| 6 | CM/PHS/22/5661/06 nonacog beta pegol (rFIX EHL) | 33600000 Pharmaceutical products | — |
| 7 | CM/PHS/22/5661/07 rFIX - Standard Half Life | 33600000 Pharmaceutical products | — |
| 8 | CM/PHS/22/5661/08 Recombinant Factor VII | 33600000 Pharmaceutical products | — |
| 9 | CM/PHS/22/5661/09 Porcine Factor VIII - susoctocog alfa | 33600000 Pharmaceutical products | — |
| 10 | CM/PHS/22/5661/10 Factor VIII Inhibitor Bypassing Fraction | 33600000 Pharmaceutical products | — |
| 11 | CM/PHS/22/5661/11 Factor IX - High Purity Factor IX | 33600000 Pharmaceutical products | — |
| 12 | CM/PHS/22/5661/12 Factor X | 33600000 Pharmaceutical products | — |
| 13 | CM/PHS/22/5661/13 Factor XIII - Plasma Derived | 33600000 Pharmaceutical products | — |
| 14 | CM/PHS/22/5661/14 Factor XIII - Recombinant | 33600000 Pharmaceutical products | — |
| 15 | CM/PHS/22/5661/15 Von willebrands factor / Factor VIII | 33600000 Pharmaceutical products | — |
| 16 | CM/PHS/22/5661/16 Von willebrands factor - Plasma Derived | 33600000 Pharmaceutical products | — |
| 17 | CM/PHS/22/5661/17 Von willebrands factor - Recombinant | 33600000 Pharmaceutical products | — |
| 18 | CM/PHS/22/5661/18 Fibrinogen Concentrate | 33600000 Pharmaceutical products | — |
| 19 | CM/PHS/22/5661/19 Prothrombin Complex dried | 33600000 Pharmaceutical products | — |
| 20 | CM/PHS/22/5661/20 Protein C Concentrate | 33600000 Pharmaceutical products | — |
| 21 | CM/PHS/22/5661/21 Fresh Frozen Plasma (all blood groups) | 33600000 Pharmaceutical products | — |
| 22 | CM/PHS/22/5661/22 Freeze Dried Plasma | 33600000 Pharmaceutical products | — |
| 23 | CM/PHS/22/5661/23 Caplacizumab | 33600000 Pharmaceutical products | — |
Awards
| Lot | Awarded to | Amount | Date |
|---|---|---|---|
| 1 | Takeda UK Ltd | £1 | — |
| 1 | Octapharma Limited | £1 | — |
| 1 | Pfizer Ltd | £1 | — |
| 2 | Novo Nordisk | £1 | — |
| 2 | Sobi (Swedish Orphan Biovitrum Ltd) | £1 | — |
| 3 | Roche Products Ltd | £1 | — |
| 4 | Sobi (Swedish Orphan Biovitrum Ltd) | £1 | — |
| 5 | CSL Behring UK Ltd | £1 | — |
| 6 | Novo Nordisk | £1 | — |
| 7 | Pfizer Ltd | £1 | — |
Official publications
| Medium | Reference | Date |
|---|---|---|
| FTS | 018011-2024 | 11 June 2024 |
Other tenders from NHS England
See the buyer →- Expressions of Interest for Childs House in the Midlands Published: 16 November 2026
- Expressions of Interest for Childs House in the Midlands Published: 16 November 2026
- Integrated Healthcare Services to HMP Ford & HMP Lewes Published: 11 November 2026
- Northamptonshire and LLR Non Custodial Services Market Engagement Event Published: 6 November 2026
- NHS Digital Weight Management Programme Published: 29 October 2026
- School Aged Immunisation Services for Kent & Medway and Sussex to NHS England South East. Published: 23 October 2026
- NHS Vaccination and Immunisation Services Published: 21 October 2026
- NHS Vaccination and Immunisation Services Published: 21 October 2026
- Hyperbaric Oxygen Therapy (HBOT) Services for all ages – Midlands Region Published: 20 October 2026
- HMP North Sea Camp - Integrated Healthcare Services Published: 20 October 2026
Previous and next from NHS England
- Workflow for NHS Lab delivering SCID Evaluation - ENLITE & EONIS Q
- Workflow for NHS Lab delivering SCID Evaluation - ENLITE BWCFT
- Culture of Care: Ward Manager Leadership Development
- Primary Care Mental Health Treatment Requirements in Leicester, Leicestershire and Rutland
- Critical Care Transfer Coordination Service (Call Handling) - East Midlands
- COVID-19 vaccination programme - 1 September 2024 to 31 March 2026
Similar open tenders
- NP43226 Nitric Oxide Therapy
- NP50427 - Ophthalmology Consumables and Associated Equipment
- Infant Feeding and Associated Accessories
- General Office Supplies 2027
- Housing Services Adaptations - Specialist Mechanical Lifting Equipment
- Supporting Community Independence - Care at Home Framework for Adults - NEW ENTRANTS
Frequently asked questions
- Who is the buyer of this tender?
- The contracting authority is NHS England (United Kingdom).
- How can I bid for public tenders in the United Kingdom?
- Bids are submitted through the official public procurement portal in the United Kingdom. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
How can I find out about similar tenders when they are published?
Create an account at el-vinculo.com and we give you a free month and set up your company's filters — contract type, CPV codes, value and territory — so you are the first to know when new tenders like this one come out in the United Kingdom. We email you as soon as one matching your profile is published, with the whole deadline ahead to prepare the bid.
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.